(No ratings)
Dr. Kenneth Jay Cohen, MD is a pediatric oncologist in Baltimore, MD specializing in pediatric oncology. Dr. Kenneth Jay Cohen, MD is affiliated with Johns Hopkins Children's Center.
He has a state license in Maryland.
Licensed In: Maryland
Dr. Kenneth Jay Cohen, MD is associated with these hospitals and organizations:
Dr. Kenneth Jay Cohen, MD does not have any reviews yet, be the first to leave a review of Dr. Kenneth Jay Cohen, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Kenneth Jay Cohen, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Genentech, Inc. |
$13,099
Avastin $13,099 |
|---|---|
| F. Hoffmann-La Roche AG |
$7,700
Avastin $7,700 |
| Day One Biopharmaceuticals |
$3,150
OJEMDA $3,150 |
| Jazz Pharmaceuticals Inc. |
$600
XYWAV $600 |
| Blueprint Medicines Corporation |
$305
AYVAKIT $305 |
| Consulting Fee | $15,880 |
|---|---|
| Travel and Lodging | $8,609 |
| Food and Beverage | $365 |
Dr. Kenneth Jay Cohen, MD has received 189 research payments totaling $9,137,149.
Dr. Cohen is Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center (SKCCC)at Johns Hopkins. He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse, NY. He did his general Pediatric Residency and Chief Residency at the University of Colorado and completed his Pediatric Hematology/Oncology Fellowship at Johns Hopkins. He has served on the faculty since 1994. His research centers on clinical trials of novel therapeutics for children with brain tumors. The Pediatric Neuro-Oncology program conducts a broad range of research centered primarily around the development and testing of novel therapeutics for children with brain tumors. The multidisciplinary nature of this work translates into continual collaboration with specialists in pediatric neurosurgery, radiation oncology, neuropathology, neuroradiology, neurology, neuro-ophthalmology, neuropsychology, and other related disciplines. Dr. Cohen is co-chair of the High-Grade Glioma committee for the Children's Oncology Group and in that capacity has a particular research interest in the development of therapeutics for the treatment of infiltrating gliomas. He serves on the scientific advisory board for numerous foundations and companies. He is on the editorial board for PDQ with responsibility for authorship of the pediatric CNS brain tumor summaries. Dr. Cohen, in his role as the Director, Strategic Partnerships for the SKCCC is responsible for planning, developing and maintaining strategic integration of cancer services and relationships with existing and potential SKCCC programs and partners. This position is designed to create a cohesive system of services and offerings that will extend the expertise of the SKCCC locally, nationally and internationally. In this role, he provides medical expertise to assure that integrated relationships benefit cancer patients, education and research.